India Glycols Limited (500201) Earnings Call Transcripts
India Glycols Limited's Latest Earnings Call - Q4 FY2026
In Q4 FY '26, India Glycols Limited reported strong financial performance with gross revenues of INR 9,827 crores, up 8.7% year-over-year, and net revenues of INR 4,211 crores, up 11.8%. The company achieved an EBITDA of INR 654 crores, reflecting a 24.5% increase, while PAT rose to INR 293 crores, up 26.8%. Management highlighted growth driven by portable spirits and biofuels, and indicated a positive outlook for the upcoming fiscal year, particularly in the premiumization of their product offerings.
Reported metrics
| Metric | Value |
|---|---|
| Gross Revenue | INR 9,827 crores (positive) |
| Net Revenue | INR 4,211 crores (positive) |
| EBITDA | INR 654 crores (positive) |
| PAT | INR 293 crores (positive) |
| EBIT Margin (Portable Spirits) | 22% (positive) |
| Debt Prepayment | INR 804 crores (positive) |
Guidance from management
Management is optimistic about FY '27, particularly in the IMFL segment, with expectations of EBIT margins exceeding 22%. They aim to continue growth in both the portable spirits and biofuels segments.
What management said
For the portable Spirits segment, I think I have already shared the number, which for Q4 was 22% the EBIT margin. Now I think the point that we've made is we've made certain assumptions in terms of ethanol, the growing market premiumization as well as strength of IVL. So I would imagine that there is no reason for us to believe that we should be able to maintain these margins and for the effort that we put in it, eve...
Saket, thank you, and thank you for your nice kind words. Just give me a second, Saket. I wanted some -- so first of all, it will be slightly incorrect to say that the performance has been muted. I think top line growth has been muted.
What analysts pressed on
Analysts expressed concerns regarding the chemicals segment's revenue decline and the impact of global market conditions on profitability. There were questions about the sustainability of margins and the effectiveness of the company's strategic initiatives in the face of competition.
Main topics on the call
- Revenue Growth in Portable Spirits — The portable spirits segment saw a top line of INR 1,331 crores, up 14.2%, driven by premiumization strategies. Management stated, "We have maintained our market leadership in the markets that we are present," indicating...
- Biofuels Segment Performance — The biofuels business delivered a remarkable 40.9% growth, achieving a top line of INR 1,470 crores. Management noted, "The government's policy of 20% blending was finished ahead of schedule," suggesting favorable regula...
- Chemicals Segment Challenges — The chemicals segment reported a net revenue decline of 10% to INR 1,203 crores, though EBIT improved by 12.5%. Management acknowledged, "We saw a significant uptick in terms of the margin percentages," indicating a focu...
- Debt Reduction and Financial Health — The company prepaid INR 804 crores in debt, resulting in a reduction of interest costs. CFO Anand Singhal stated, "This will continue to reduce our interest cost in the years to come," signaling improved financial stabil...
Read the full India Glycols Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About India Glycols Limited
India Glycols Limited (500201) is a publicly listed company in the Chemicals industry, within the Materials sector. It trades on BSE and is based in IN. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 11 calls on record spanning February 5, 2024 to August 14, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 11 India Glycols Limited earnings call transcripts on record, spanning February 5, 2024 to August 14, 2026. Based on this history, India Glycols Limited reports quarterly. The most recent call on file is dated August 14, 2026. The full list is below — each row opens the complete, free-to-read transcript.
| Quarter | Date | |
|---|---|---|
| Q1 FY2027 | Aug 14, 2026 | Read transcript → |
| Q4 FY2026 | May 18, 2026 | Read transcript → |
| Q3 FY2026 | Feb 12, 2026 | Read transcript → |
| Q2 FY2026 | Nov 18, 2025 | Read transcript → |
| Q1 FY2026 | Aug 11, 2025 | Read transcript → |
| Q4 FY2025 | May 21, 2025 | Read transcript → |
| Q3 FY2025 | Feb 6, 2025 | Read transcript → |
| Q2 FY2025 | Nov 8, 2024 | Read transcript → |
| Q1 FY2025 | Jul 31, 2024 | Read transcript → |
| Q4 FY2024 | May 30, 2024 | Read transcript → |
| Q3 FY2024 | Feb 5, 2024 | Read transcript → |